Trials / Completed
CompletedNCT03339947
French Travelers' Knowledge of Risk of Acquiring ESBL-PE
Poor Knowledge Among French Travelers of the Risk of Acquiring Multidrug-resistant Bacteria During Travel
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 191 (actual)
- Sponsor
- CHU de Reims · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to determine, among French travelers attending a consultation for travel medicine, patients level of knowledge about the risk of acquiring MRE.
Detailed description
Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, The investigators aimed to assess, among persons attending a consultation for travel medicine and international vaccines, patients level of knowledge regarding the risk of acquiring MRE, preventive behaviours and the need to inform health professionals that they had recently travelled if the patients require medical care after their return. A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital, France. All adult travellers who attended this consultation between January 2016 and May 2016 and who completed the questionnaire were included in the study. The questionnaire was completed before the planned travel. The travellers answered the questionnaires before seeing the physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-05-01
- Completion
- 2016-06-01
- First posted
- 2017-11-13
- Last updated
- 2017-11-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03339947. Inclusion in this directory is not an endorsement.